Redesca HP (Enoxaparin)

Redesca HP is a low molecular weight heparin (LMWH) indicated for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). This anticoagulant is also used in the management of unstable angina and myocardial infarction. Redesca HP is derived from porcine intestinal mucosa and is administered through subcutaneous injection.

Before you buy Redesca, it is crucial that you talk to your healthcare provider about potential side effects and effectiveness.

Directions

Dosage:

For DVT and PE Prevention: Typically, the dosage is 20 mg once daily for patients with low to moderate risk of thromboembolic complications, and 40 mg once daily for those with a higher risk. This medication is usually administered for 7 to 10 days, or as directed by a healthcare provider.

For DVT and PE Treatment: The recommended dose is 1 mg/kg body weight, administered subcutaneously every 12 hours. For patients requiring less frequent dosing, 1.5 mg/kg body weight once daily may be prescribed.

For Unstable Angina or Myocardial Infarction: Typically, 1 mg/kg every 12 hours in combination with oral antiplatelet therapy.

Administration:

Ensure proper technique is used for subcutaneous injections. Inject in fatty areas such as the abdomen or thigh.

Do not mix with other injections or solutions.

Rotate injection sites to prevent skin irritation.

Ingredients

Active Ingredient: Enoxaparin sodium.

Cautions

Redesca HP should not be used by patients who are allergic to enoxaparin, heparin, or pork products.

Exercise caution when administering to individuals with a past occurrence of heparin-induced thrombocytopenia (HIT).

Not recommended for patients with active major bleeding or conditions that predispose them to bleeding.

Patients with reduced kidney function may require dosage adjustments or additional monitoring to prevent bleeding complications.

Consult a healthcare provider regarding enoxaparin injection use during pregnancy, as it may cross the placenta.

Interactions

Anticoagulants and antiplatelets: Increased risk of bleeding if used with other drugs that affect blood clotting, such as warfarin, aspirin, and clopidogrel.

Nonsteroidal anti-inflammatory drugs (NSAIDs): Can increase bleeding risk; monitor closely if concurrent use is necessary.

Herbal supplements: Avoid concomitant use of supplements that have anticoagulant effects, such as Ginkgo biloba, garlic, and high doses of fish oil.

Side Effects

Common side effects include:

• Injection site reactions (pain, bruising, redness, or swelling)
• Bleeding
• Anemia

If you are curious about enoxaparin uses, consult with your healthcare provider to understand its potential benefits and risks for your specific medical condition.